These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

122 related items for PubMed ID: 6500782

  • 1. Prevention and treatment of L1210 mouse leukemia by immunization with xenogenized tumor cells combined with immunostimulation by the P40 fraction of C. granulosum and chemotherapy.
    Relyveld EH, Bizzini B, Ben-Efraim S.
    Int J Immunopharmacol; 1984; 6(5):445-50. PubMed ID: 6500782
    [Abstract] [Full Text] [Related]

  • 2. Synergy between low-dose chemotherapy and immunotherapy in mouse L1210 leukemia.
    Relyveld EH, Bizzini B, Ophir R, Ben-Efraim S.
    Cancer Treat Rep; 1987 Mar; 71(3):241-6. PubMed ID: 3102055
    [Abstract] [Full Text] [Related]

  • 3. [Prevention and therapy of L1210 leukemia in mice, using inactivated and grafted tumor cells, in association with the immunomodulator P40, and Antineoplastic Agents (author's transl)].
    Relyveld EH, Bizzini B, Ben-Efraim S.
    C R Seances Acad Sci III; 1982 Mar 22; 294(12):571-6. PubMed ID: 6809234
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Active immunotherapy of L1210 leukaemia applied after the graft of tumour cells.
    Mathé G, Pouillart P, Lapeyraque F.
    Br J Cancer; 1969 Dec 22; 23(4):814-24. PubMed ID: 4312660
    [No Abstract] [Full Text] [Related]

  • 6. Successful chemoimmunotherapy of murine L1210 lymphatic leukemia with cyclophosphamide and mafosfamide-treated leukemia cells.
    Kawalec M, Skórski T, Kawiak J.
    Invest New Drugs; 1988 Sep 22; 6(3):169-72. PubMed ID: 3192382
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Therapeutic effectiveness of neuraminidase-treated tumor cells as an immunogen in man and experimental animals with leukemia.
    Bekesi JG, Roboz JP, Holland JF.
    Ann N Y Acad Sci; 1976 Sep 22; 277(00):313-31. PubMed ID: 1069551
    [Abstract] [Full Text] [Related]

  • 9. Combination of immunotherapy with cyclophosphamide/actinomycin D chemotherapy potentiates antileukemic effect and reduces toxicity in a L1210 leukemia model in mice.
    Lasek W, Sora M, Wańkowicz A, Jakóbisiak M.
    Cancer Lett; 1995 Feb 10; 89(1):137-43. PubMed ID: 7882296
    [Abstract] [Full Text] [Related]

  • 10. Effective chemo-immunotherapy of L1210 leukemia in vivo using interleukin-12 combined with doxorubicin but not with cyclophosphamide, paclitaxel or cisplatin.
    Zagozdzon R, Gołab J, Stokłosa T, Giermasz A, Nowicka D, Feleszko W, Lasek W, Jakóbisiak M.
    Int J Cancer; 1998 Aug 31; 77(5):720-7. PubMed ID: 9688305
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Induction of transplantation resistance to murine L1210 leukemia cells in BCG-primed mice by immunization with tuberculin protein-coupled L1210 cells.
    Ohno R, Kodera Y, Ogura M, Yamada H.
    Gan; 1984 Feb 31; 75(2):187-92. PubMed ID: 6428959
    [Abstract] [Full Text] [Related]

  • 14. Synergistic effects of Actinobacillus suis cells in combination with 5-fluorouracil on mice bearing murine L1210 leukemia cells.
    Watanabe T, Itoh S.
    Cancer Immunol Immunother; 1997 Jun 31; 44(4):216-20. PubMed ID: 9222280
    [Abstract] [Full Text] [Related]

  • 15. Effect of forphenicinol on the production of Ia-positive macrophages in mice with or without L1210 leukemia and on the growth of L1210 in immunized mice.
    Okura A, Arakawa H, Yoshinari T, Naito K, Ishizuka M, Takeuchi T, Umezawa H.
    J Antibiot (Tokyo); 1986 Apr 31; 39(4):575-80. PubMed ID: 3458691
    [Abstract] [Full Text] [Related]

  • 16. Immunotherapy of L1210 leukemia using neuraminidase-modified plasma membranes combined with chemotherapy.
    Pincus JH, Jameson AK, Brandt AE.
    Cancer Res; 1981 Aug 31; 41(8):3082-6. PubMed ID: 7248965
    [Abstract] [Full Text] [Related]

  • 17. Effect of forphenicinol, a small molecular immunomodifier, in combination with cyclophosphamide on growth of and immunity to syngeneic murine tumors.
    Nitta K, Tanaka T, Takeuchi M.
    Cancer Treat Rep; 1985 Mar 31; 69(3):285-91. PubMed ID: 3978657
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The use of systemic immunity adjuvants in the prophylaxis or therapy of cancer.
    Mathé G, Halle-Pannenko O, Bourut C, Hiu IJ.
    Johns Hopkins Med J Suppl; 1974 Mar 31; 3():85-102. PubMed ID: 4154074
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.